All News

Community pharmacists are in a unique position to counsel caregivers on liquid children’s products

Researchers from Gilead remain confident for positive results as they continue the phase 3 EVOKE-03 study in 1L metastatic PD-L1-high NSCLC.

RSV can exacerbate asthma development by causing damage to the tissue in the airways, promoting inflammation and increasing airway hyper-responsiveness

However, increasing dietary niacin did not reduce risk of mortality from cardiovascular disease, the primary cause of death associated with nonalcoholic fatty liver disease.

Living organisms rely on iron for survival and replication. Can new research discoveries disrupt C. difficile’s ability to maintain iron homeostasis?

Nearly 60% of patients who regained all the weight stayed in remission at 5 years post-surgery, according to study results.

Certain patients may present asymptomatically, affecting treatment options.

Pharmacists can raise awareness about heart health during American Heart Month

Targeted use of ultraviolet light and sporicidal treatment can reduce disease transmission alongside existing interventions.

The full scope of pharmacy practice offers a transformative approach to health care delivery, promising improved patient outcomes, greater access to care, and efficient utilization of health care resources.

Cardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.

Despite the proven efficacy of biosimilars, both patients and health care providers often have some reluctance when switching from an originator drug to a biosimilar.

This Valentine’s Day, remind patients to focus on their heart health

The pharmacist’s role may vary across different practices and institutions.

California's Stop Dangerous Pharmacies Act aims to improve patient safety by establishing new pharmacy staffing regulations and a medication error reporting system, arising from understaffed conditions.

This marks the first and only time that an individualized T cell therapy has been approved by the FDA for a solid tumor cancer.

This marks omalizumab’s fourth FDA-approved indication for allergic and inflammatory conditions, such as severe persistent allergic asthma, with its initial approval being in 2003.

Children with heart disease who received infant open-heart surgery had more stress and neurodevelopmental impairments compared with children who did not undergo surgery.

Pharmacists can host community events and try different marketing efforts to drive community awareness about heart health and total health.

Tigilanol tiglate is a novel, small molecule drug for the intratumoral treatment of solid tumors, inducing tumor cell death and stimulating immune response.

Taking a few seconds to double-check a prescription can have significant impacts on patient safety

Tucatinib significantly improved median PFS in the overall population and those with brain metastases.

The complexity of the disease and number of treatment options can necessitate a personalized approach.

With a wide array of OTC products, pharmacists can help patients select the right regimen

One significant difference was an increased rate of bupropion prescriptions for transgender females.